Table of Contents
Chromatography Research International
Volume 2011, Article ID 404189, 5 pages
http://dx.doi.org/10.4061/2011/404189
Research Article

Stability-Indicating HPTLC Method for Determination of Duloxetine Hydrochloride in Bulk Drug and Tablet Formulation

1Department of Pharmacy, Lloyd College, Knowledge Park II, Greater Noida 201306, India
2Ranbaxy Research Labs, Haryana, Gurgaon 122001, India

Received 18 June 2011; Accepted 21 July 2011

Academic Editor: Antonio Martín-Esteban

Copyright © 2011 Sheikh Shahnawaz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Viktrup and R. C. Bump, “Pharmacological agents used for the treatment of stress urinary incontinence in women,” Current Medical Research and Opinion, vol. 19, no. 6, pp. 485–490, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. J. F. Wernicke, Y. L. Pritchett, D. N. D'Souza et al., “A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain,” Neurology, vol. 67, no. 8, pp. 1411–1420, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. W. A. Marcil and F. Petty, “Duloxetine associated with smoking cessation,” Annals of Pharmacotherapy, vol. 39, no. 9, pp. 1578–1579, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. D. Tincello, M. Sculpher, R. Tunn et al., “Patient characteristics impacting health state index scores, measured by the EQ-5D of females with stress urinary incontinence symptoms,” Value in Health, vol. 13, no. 1, pp. 112–118, 2010. View at Publisher · View at Google Scholar · View at PubMed
  5. R. C. Shelton, A. C. Andorn, C. H. Mallinckrodt et al., “Evidence for the efficacy of duloxetine in treating mild, moderate, and severe depression,” International Clinical Psychopharmacology, vol. 22, no. 6, pp. 348–355, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. P. Soni, T. T. Mariappan, and U. C. Banerjee, “High-performance liquid chromatographic method for the simultaneous estimation of the key intermediates of duloxetine,” Talanta, vol. 67, no. 5, pp. 975–978, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. P. J. Jansen, P. L. Oren, C. A. Kemp, S. R. Maple, and S. W. Baertschi, “Characterization of impurities formed by interaction of duloxetine HCl with enteric polymers hydroxypropyl methylcellulose acetate succinate and hydroxypropyl methylcellulose phthalate,” Journal of Pharmaceutical Sciences, vol. 87, no. 1, pp. 81–85, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. G. S. Clarke, “The validation of analytical methods for drug substances and drug products in UK pharmaceutical laboratories,” Journal of Pharmaceutical and Biomedical Analysis, vol. 12, no. 5, pp. 643–652, 1994. View at Publisher · View at Google Scholar · View at Scopus